Form 4 holding
Director
ALNYLAM PHARMACEUTICALS, INC.
- Security class
- Stock Option (right to buy)
- Shares / value
- 3,454
- Estimated value
- Report date
- 18 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount